Microcurrent and Aerobic Exercise Effects in Abdominal Fat

October 23, 2014 updated by: Andreia Noites, Escola Superior de Tecnologia da Saúde do Porto

Microcurrent and Aerobic Exercise Effects in Glycerol, Catecholamines, Energetic Source and Muscle Activity

The purpose of this study was to analyze microcurrent short term effects used with aerobic exercise on abdominal fat.

Study Overview

Detailed Description

Nutritional patterns have been changed during twenty-first century with sugar and fat's high proportions that allied to sedentary lifestyle increased body fat. There is already a well establish relationship between total body fat excess, cardiometabolic diseases and increased mortality, knowing that abdominal fat (android pattern), different from body index, presents an additional influence to health risks. Women with their abdominal adipocytes (visceral fat) show an increased lipolytic activity that releases free fat acids to the systemic and portal circulation leading to a metabolic syndrome, increasing the risk of cardiovascular diseases.

Aerobic exercise is a way to decrease fat as it stimulates lipolysis through an increase in catecholamine's level resulting from a sympathetic system nervous activity raise. The most used exercise for lipid elimination is the prolonged aerobic moderate exercise with a minimum of 30 minutes.

Nevertheless aerobic exercise practice reduce globally lipidic sources and not locally .

Electrolipolysis using microcurrent has been used in clinical practice as a technique to reduce abdominal fat. This technique can be applied transcutaneously or percutaneously seeming that the former is not so effective as skin can be an obstacle to the current effect on visceral and subcutaneous fat .

Abdominal fat excess is associated with cardiometabolic diseases and can be prevented using microcurrent and aerobic exercise to stimulate lipolysis.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Porto
      • Vila Nova de Gaia, Porto, Portugal, 4400-303
        • Andreia Noites

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 18 and 30 years.

Exclusion Criteria:

  • submitted to other fat reduce procedure, to show cardiovascular risk factors or diseases and/or any physical condition limiting aerobic exercise. To present any contraindications to microcurrent and/or aerobic exercise, to take medication that influence lipid metabolism, and to be pregnant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transcutaneous microcurrent
This group performed aerobic exercise just after microcurrent in the abdominal region with four transcutaneous electrodes in a parallel position, intensity below the sensitivity threshold and a maximum of 1 milliampere (mA). Every 20 minutes changed from 25 hertz (Hz) to 10 Hz
Microcurrent in the abdominal region with four transcutaneous electrodes in a parallel position, intensity below the sensitivity threshold and a maximum of 1 mA. Every 15 minutes changed from 25 Hz to 10 Hz.
50 minutes of aerobic moderate-intensity exercise (45-55% of maximal oxygen consumption (VO2 max)) using Karvonen´s formula, performed on a cycloergometer. Were used Borg scale (12-13), Polar® heart monitors to control heart rate and K4b2 to analyze the quantity of oxygen (O2) consumption and carbon dioxide (CO2) produced during exercise.
Placebo Comparator: Control group
Control group performed aerobic exercise just after microcurrent in the abdominal region with four transcutaneous electrodes in a parallel position, but microcurrent device was switched off.
50 minutes of aerobic moderate-intensity exercise (45-55% of maximal oxygen consumption (VO2 max)) using Karvonen´s formula, performed on a cycloergometer. Were used Borg scale (12-13), Polar® heart monitors to control heart rate and K4b2 to analyze the quantity of oxygen (O2) consumption and carbon dioxide (CO2) produced during exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in catecholamines and glycerol concentrations
Time Frame: 10 minutes before the interventions, after interventions (duration of interventions - 90 minutes) and after 24 hours
Blood analysis collection was carried out with help from an clinical analysis technician. The volunteers were not fasting.
10 minutes before the interventions, after interventions (duration of interventions - 90 minutes) and after 24 hours
Change in proportion of energy source
Time Frame: Immediately before (for 3 minutes) and during exercise (duration of exercise - 50 minutes)
K4b2 (COSMED ®) was used for analysis of cardiopulmonary gas exchange in real time.
Immediately before (for 3 minutes) and during exercise (duration of exercise - 50 minutes)
Change in electromyographic activity
Time Frame: 5 minutes before and after microcurrent
Recording the surface electrical activity produced by rectus abdominis and external oblique in front bridge and side bridge exercise, respectively.
5 minutes before and after microcurrent

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subcutaneous abdominal fat and visceral abdominal fat
Time Frame: 20 minutes before the interventions
Ultrasound was performed at the end of expiration to measure subcutaneous abdominal fat between xiphoid apophysis and navel, below navel, and above left and right anterior superior iliac spine. Between xiphoid apophysis and navel was also measured visceral abdominal fat. Abdominal fat analyzed by dual-energy x-ray absorptiometry (DEXA).
20 minutes before the interventions
Suprailiac, vertical and horizontal abdominal skinfolds
Time Frame: 20 minutes before the interventions
Suprailiac, vertical and horizontal abdominal skinfolds were performed two times in right hemi body, by caliper.
20 minutes before the interventions
Perimeters measurements
Time Frame: 20 minutes before the interventions

The perimeters measurements were done, at the end of expiration, at waist level (below last rib), at navel level, at the point immediately above the iliac crests and at trochanters level. The waist-hip ratio was calculated using the waist level perimeter.

divided by trochanters level perimeter.

20 minutes before the interventions
Change in cholesterol, triglycerides and glucose concentrations
Time Frame: 10 minutes before the interventions, after interventions (duration of interventions - 90 minutes)
Blood analysis collection was carried out with help from an clinical analysis technician. The volunteers were not fasting.
10 minutes before the interventions, after interventions (duration of interventions - 90 minutes)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Physical Activity Questionnaire
Time Frame: 30 minutes before the interventions
Used to evaluate the level of physical activity of the volunteers
30 minutes before the interventions
Food Frequency Questionnaire
Time Frame: 30 minutes before the interventions
Used to evaluate the lifestyle of the volunteers
30 minutes before the interventions
Bioimpedance values
Time Frame: 30 minutes before the interventions
The height was measured with the volunteers on respiratory apnea. To minimize the influence of electrolyte balance changes in bioimpedance assessment, was given some rules to volunteers. It was calculated BMI using the body weight divided by height squared
30 minutes before the interventions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Rui Vilarinho, BSc, Escola Superior de Tecnologia da Saúde do Porto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

March 21, 2014

First Submitted That Met QC Criteria

April 7, 2014

First Posted (Estimate)

April 10, 2014

Study Record Updates

Last Update Posted (Estimate)

October 24, 2014

Last Update Submitted That Met QC Criteria

October 23, 2014

Last Verified

October 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Abdominal

Clinical Trials on Transcutaneous microcurrent

3
Subscribe